Growth arrest specific 2-like protein 1 expression is upregulated in podocytes through advanced glycation end-products

Nephrology Dialysis Transplantation

Volumn 32, Issue 4, 2017, Pages 641-653

  Liebisch, Marita ^a   Bondeva, Tzvetanka ^a   Franke, Sybille ^a   Hause, Stephan ^a,b   Wolf, Gunter ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

AGEs; GAS2; GAS2L1; RAGE

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; BOVINE SERUM ALBUMIN; CELL PROTEIN; GAS2L1 ALPHA PROTEIN; GROWTH ARREST SPECIFIC 2 PROTEIN; GROWTH ARREST SPECIFIC 2-LIKE PROTEIN 1; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; RECOMBINANT RECEPTOR; REGULATOR PROTEIN; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; GAS2 PROTEIN, MOUSE; SRAGE PROTEIN, HUMAN;

ADVANCED GLYCATION END PRODUCT BLOOD LEVEL; ALBUMINURIA; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BLOOD LEVEL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GAS2 GENE; GAS2L1 ALPA GENE; GENE; GENE EXPRESSION; GLOMERULUS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION; ANIMAL; APOPTOSIS; BOVINE; CELL CULTURE; CYTOLOGY; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; APOPTOSIS; CATTLE; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; GLYCOSYLATION END PRODUCTS, ADVANCED; MICE; MICROFILAMENT PROTEINS; PODOCYTES; REAL-TIME POLYMERASE CHAIN REACTION; SERUM ALBUMIN, BOVINE; UP-REGULATION;

EID: 85019168372     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfw313     Document Type: Article

References (39)

1. Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest ofmammalian cells. Cell 1988; 54: 787-793
2. Del Sal G, Collavin L, Ruaro ME et al. Structure, function, and chromosome mapping of the growth-suppressing human homologue of the murine gas1 gene. Proc Natl Acad Sci USA 1994; 91: 1848-1852
3. Evdokiou A, Cowled PA. Growth-regulatory activity of the growth arrestspecific gene, GAS1, in NIH3T3 fibroblasts. Exp Cell Res 1998; 240: 359-367
4. Zamorano A, Mellstrom B, Vergara P et al. Glial-specific retrovirally mediated gas1 gene expression induces glioma cell apoptosis and inhibits tumor growth in vivo. Neurobiol Dis 2004; 15: 483-491
5. Lee KK, Leung AK, Tang MK et al. Functions of the growth arrest specific 1 gene in the development of the mouse embryo. Dev Biol 2001; 234: 188-203
6. Kann M, Bae E, LenzMO et al.WT1 targets Gas1 tomaintain nephron progenitor cells by modulating FGF signals. Development 2015; 142: 1254-1266
7. Nagai K, Arai H, Yanagita M et al. Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J Biol Chem 2003; 278: 18229-18234
8. Nagai K, Matsubara T, Mima A et al. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. Kidney Int 2005; 68: 552-561
9. Yanagita M, Ishimoto Y, Arai H et al. Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. J Clin Invest 2002; 110: 239-246
10. Brancolini C, Schneider C. Phosphorylation of the growth arrest-specific protein Gas2 is coupled to actin rearrangements during Go->G1 transition in NIH 3T3 cells. J Cell Biol 1994; 124: 743-756
11. Brancolini C, Bottega S, Schneider C. Gas2, a growth arrest-specific protein, is a component of the microfilament network system. J Cell Biol 1992; 117: 1251-1261
12. Brancolini C, Benedetti M, Schneider C. Microfilament reorganization during apoptosis: the role of Gas2, a possible substrate for ICE-like proteases. EMBO J 1995; 14: 5179-5190
13. Sgorbissa A, Benetti R, Marzinotto S et al. Caspase-3 and caspase-7 but not caspase-6 cleave Gas2 in vitro: implications for microfilament reorganization during apoptosis. J Cell Sci 1999; 112 (Pt 23): 4475-4482
14. Benetti R, Del Sal G, Monte M et al. The death substrate Gas2 binds m-calpain and increases susceptibility to p53-dependent apoptosis. EMBO J 2001; 20: 2702-2714
15. Pavenstadt H, KrizW, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003; 83: 253-307
16. Barisoni L, Mundel P. Podocyte biology and the emerging understanding of podocyte diseases. Am J Nephrol 2003; 23: 353-360
17. Cheng H, Harris RC. The glomerulus-a view from the outside-the podocyte. Int J Biochem Cell Biol 2010; 42: 1380-1387
18. Fioretto P, Mauer M. Histopathology of diabetic nephropathy. Semin Nephrol 2007; 27: 195-207
19. Pagtalunan ME, Miller PL, Jumping-Eagle S et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997; 99: 342-348
20. Mallipattu SK, Uribarri J. Advanced glycation end product accumulation: A new enemy to target in chronic kidney disease Curr Opin Nephrol Hypertens 2014; 23: 547-554
21. Stieger N, Worthmann K, Schiffer M. The role of metabolic and haemodynamic factors in podocyte injury in diabetes. Diabetes Metab Res Rev 2011; 27: 207-215
22. Bondeva T, Ruster C, Franke S et al. Advanced glycation end-products suppress neuropilin-1 expression in podocytes. Kidney Int 2009; 75: 605-616
23. Zucman-Rossi J, Legoix P, Thomas G. Identification of new members of the Gas2 and Ras families in the 22q12 chromosome region. Genomics 1996; 38: 247-254
24. Goriounov D, Leung CL, Liem RK. Protein products of human Gas2-related genes on chromosomes 17 and 22 (hGAR17 and hGAR22) associate with both microfilaments and microtubules. J Cell Sci 2003; 116 (Pt 6): 1045-1058
25. Stroud MJ, Nazgiewicz A, McKenzie EA et al. GAS2-like proteins mediate communication between microtubules and actin through interactions with end-binding proteins. J Cell Sci 2014; 127 (Pt 12): 2672-2682
26. Mundel P, Reiser J, ZunigaMejia Borja A et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 1997; 236: 248-258
27. Busch M, Franke S, Wolf G et al. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension. Am J Kidney Dis 2006; 48: 571-579
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408
29. Kobayashi K, Forte TM, Taniguchi S et al. The db/db mouse, a model for diabetic dyslipidemia:molecular characterization and effects of Western diet feeding.Metabolism 2000; 49: 22-31
30. Liebisch M, Bondeva T, Franke S et al. Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 suppression. Kidney Int 2014; 86: 103-117
31. D'Agati V, Yan SF, Ramasamy R et al. RAGE, glomerulosclerosis and proteinuria: roles in podocytes and endothelial cells. Trends Endocrinol Metab 2010; 21: 50-56
32. Makita Z, Vlassara H, Cerami A et al. Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 1992; 267: 5133-5138
33. Berg TJ, Bangstad HJ, Torjesen PA et al. Advanced glycation end products in serum predict changes in the kidneymorphology of patients with insulindependent diabetes mellitus.Metabolism 1997; 46: 661-665
34. Busch M, Franke S, Ruster C et al. Advanced glycation end-products and the kidney. Eur J Clin Invest 2010; 40: 742-755
35. Cohen MP, Shearman CW. Inhibiting Amadori-modified albumin formation improves biomarkers of podocyte damage in diabetic rats. Physiol Rep 2013; 1: e00083
36. Ruster C, Bondeva T, Franke S et al. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes. Nephrol Dial Transplant 2008; 23: 2179-2191
37. Stinghen AEM, Massy ZA, Vlassara H et al. Uremic toxicity of advanced glycation end products in CKD. J Am Soc Nephrol 2016; 354-370
38. Arai H, Nagai K, Doi T. Role of growth arrest-specific gene 6 in diabetic nephropathy. Vitam Horm 2008; 78: 375-392
39. Wolf G, Schanze A, Stahl RA et al. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency. Kidney Int 2005; 68: 1583-1589